{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:36:13Z","timestamp":1788568573244,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ijpharm.2013.07.005","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T08:17:21Z","timestamp":1373444241000},"page":"4-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Eluting combination drugs from stents"],"prefix":"10.1016","volume":"454","author":[{"given":"Rajesh","family":"Thipparaboina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Domb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2013.07.005_bib0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2147\/vhrm.2007.3.2.191","article-title":"Sirolimus-eluting coronary stents: a review","volume":"3","author":"Abizaid","year":"2007","journal-title":"Vasc. Health Risk Manage."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0010","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jacc.2007.02.021","article-title":"Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial","volume":"49","author":"Adriaenssens","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00059-011-3458-z","article-title":"Second-and third-generation drug-eluting coronary stents","volume":"36","author":"Akin","year":"2011","journal-title":"Herz"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0020","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.101.12.1453","article-title":"Inhibition of neointima formation after experimental coronary artery stenting a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost","volume":"101","author":"Alt","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ccd.21299","article-title":"Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model","volume":"70","author":"Berg","year":"2007","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0030","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1021\/la300808z","article-title":"Pore networks and polymer rearrangement on a drug-eluting stent as revealed by correlated confocal raman and atomic force microscopy","volume":"28","author":"Biggs","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0035","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2010.03.020","article-title":"2-Year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor, drug-eluting stents","volume":"55","author":"Byrne","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0040","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/eurheartj\/ehp044","article-title":"A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents","volume":"30","author":"Byrne","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0045","doi-asserted-by":"crossref","first-page":"19347","DOI":"10.1073\/pnas.1115945108","article-title":"In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid\u2013polymeric nanoparticles","volume":"108","author":"Chan","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0050","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1073\/pnas.0914585107","article-title":"Spatiotemporal controlled delivery of nanoparticles to injured vasculature","volume":"107","author":"Chan","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s003950170043","article-title":"Magnolol, a potent antioxidant from Magnolia officinalis, attenuates intimal thickening and MCP-1 expression after balloon injury of the aorta in cholesterol-fed rabbits","volume":"96","author":"Chen","year":"2001","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00005344-200311000-00014","article-title":"Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery","volume":"42","author":"Danenberg","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0065","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1161\/01.CIR.0000097002.69209.CD","article-title":"Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits","volume":"108","author":"Danenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MCA.0b013e328333f550","article-title":"Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent","volume":"21","author":"Doostzadeh","year":"2010","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nrd1345","article-title":"siRNAs: applications in functional genomics and potential as therapeutics","volume":"3","author":"Dorsett","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2013.01.053","article-title":"Crystalline coating of rapamycin onto a stent: process development and characterization","volume":"445","author":"Farah","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0085","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.biotechadv.2012.12.010","article-title":"Evolution of covered stents in the contemporary era: clinical application, materials and manufacturing strategies using nanotechnology","volume":"31","author":"Farhatnia","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/hrt.2009.189522","article-title":"Drug-eluting stents: a reappraisal","volume":"96","author":"Garg","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCINTERVENTIONS.109.919936","article-title":"Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrixclinical perspective","volume":"3","author":"Granada","year":"2010","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0100","series-title":"Price discrimination and bargaining: empirical evidence from medical devices","author":"Grennan","year":"2012"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0105","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","volume":"107","author":"Hedman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0110","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1016\/j.actbio.2013.01.013","article-title":"Bioactive coronary stent coating based on layer-by-layer technology for siRNA release","volume":"9","author":"Hossfeld","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0115","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.biomaterials.2010.01.147","article-title":"In vitro and in vivo performance of a dual drug-eluting stent (DDES)","volume":"31","author":"Huang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0120","first-page":"1","article-title":"Coronary stents: historical development, current status and future directions","author":"Iqbal","year":"2013","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents","volume":"52","author":"Joner","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0130","first-page":"595","article-title":"Very late stent thrombosis with newer drug-eluting stents: no longer an issue?","volume":"65","author":"Jos\u00e9","year":"2012","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0135","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1517\/14656566.2.11.1903","article-title":"Sirolimus: a comprehensive review","volume":"2","author":"Kahan","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0140","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.bbagen.2012.12.015","article-title":"Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1\/2 and NF-\u03baB activation in vascular smooth muscle cells","volume":"1830","author":"Karki","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jconrel.2012.02.010","article-title":"Drug eluting stents: developments and current status","volume":"161","author":"Khan","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2013.02.012","article-title":"Carrier free rapamycin loaded drug eluting stent: in vitro and in vivo evaluation","volume":"168","author":"Khan","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jbm.b.31894","article-title":"Synergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devices","volume":"99","author":"Kleinedler","year":"2011","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2012.01.008","article-title":"Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization","volume":"159","author":"Kleinedler","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0165","article-title":"Effect of cilostazol on the pharmacokinetics of simvastatin in healthy volunteers","volume":"91","author":"Ko","year":"2012","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0170","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1152\/japplphysiol.01329.2003","article-title":"Stent design properties and deployment ratio influence indexes of wall shear stress: a three-dimensional computational fluid dynamics investigation within a normal artery","volume":"97","author":"LaDisa","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1475-925X-4-59","article-title":"Axial stent strut angle influences wall shear stress after stent implantation: analysis using 3D computational fluid dynamics models of stent foreshortening","volume":"4","author":"LaDisa","year":"2005","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0180","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMe1001069","article-title":"Second-generation drug-eluting coronary stents","volume":"362","author":"Lange","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0185","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1161\/01.CIR.0000044020.27990.32","article-title":"Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent implications for rational therapy of restenosis","volume":"106","author":"Lanza","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0190","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2010.11.021","article-title":"Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions","volume":"107","author":"Lee","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0195","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1021\/la300364y","article-title":"Surface crystallization of rapamycin on stents using a temperature induced process","volume":"28","author":"Levy","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0200","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jpba.2010.10.027","article-title":"Paclitaxel\/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies","volume":"54","author":"Ma","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10557-007-6036-0","article-title":"The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation","volume":"21","author":"Manickavasagam","year":"2007","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/clc.20066","article-title":"Systemic nanoparticle Paclitaxel (nab-Paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study","volume":"30","author":"Margolis","year":"2007","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0215","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4244\/EIJV7I8A155","article-title":"Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials","volume":"7","author":"Navarese","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ccd.10339","article-title":"Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model","volume":"57","author":"New","year":"2002","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2006.08.023","article-title":"Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents","volume":"116","author":"Pan","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2012.03.019","article-title":"Dual drug-eluting stent","volume":"159","author":"Park","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0235","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jbm.b.31954","article-title":"Control of cilostazol release kinetics and direction from a stent using a reservoir-based design","volume":"100","author":"Parker","year":"2012","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0240","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2006.10.013","article-title":"Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis","volume":"117","author":"Patil","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/157016113804547575","article-title":"Preclinical evaluation of coronary stents: focus on safety issues","volume":"11","author":"Perez","year":"2013","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0250","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2012.02.007","article-title":"PCL films incorporated with paclitaxel\/5-fluorouracil: Effects of formulation and spacial architecture on drug release","volume":"427","author":"Rong","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0255","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1021\/bm900740g","article-title":"Development of a functionalized polymer for stent coating in the arterial delivery of small interfering RNA","volume":"10","author":"San Juan","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/2008-2231-20-45","article-title":"Drug\u2013drug co-crystals","volume":"20","author":"Sekhon","year":"2012","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/vhrm.2008.04.01.31","article-title":"Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V\u00ae)","volume":"4","author":"Sheiban","year":"2008","journal-title":"Vasc. Health Risk Manage."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0270","first-page":"2013","article-title":"Anti-inflammatory effects of arsenic trioxide eluting stents in a porcine coronary model","author":"Shen","year":"2013","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0275","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1039\/b910351a","article-title":"Preparation of a dual-drug-eluting stent by grafting of ALA with abciximab on a bare metal stent","volume":"19","author":"Song","year":"2009","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0280","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1039\/b910351a","article-title":"Preparation of a dual-drug-eluting stent by grafting of ALA with abciximab on a bare metal stent","volume":"19","author":"Song","year":"2009","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00392-002-1310-4","article-title":"Sirolimus-eluting stents: a review of experimental and clinical findings","volume":"91","author":"Toutouzas","year":"2002","journal-title":"Z. Kardiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5551\/jat.13862","article-title":"Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model","volume":"20","author":"Tsukie","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0300","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ccd.24473","article-title":"Succinobucol-eluting stents increase neointimal thickening and peri-strut inflammation in a porcine coronary model","volume":"81","author":"Watt","year":"2013","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/CS20070207","article-title":"Pro-healing drug-eluting stents: a role for antioxidants?","volume":"114","author":"Watt","year":"2008","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0310","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/CIRCULATIONAHA.104.486647","article-title":"Randomized comparison of a titanium-nitride-oxide\u2013coated stent with a stainless steel stent for coronary revascularization the TiNOX trial","volume":"111","author":"Windecker","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0315","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcmg.2008.06.003","article-title":"Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis","volume":"1","author":"Winter","year":"2008","journal-title":"JACC: Cardiovasc. Imaging"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0320","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.biomaterials.2012.11.006","article-title":"The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent","volume":"34","author":"Yang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0325","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yjmcc.2013.02.002","article-title":"Endogenous CGRP protects against neointimal hyperplasia following wire-induced vascular injury","volume":"59","author":"Yang","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0330","first-page":"1109","article-title":"First-in-man study of simvastatin-eluting stent in de novo coronary lesions: the SIMVASTENT study","volume":"76","author":"Zago","year":"2012","journal-title":"Circ. J. Off. J. Jpn. Circ. Soc."},{"key":"10.1016\/j.ijpharm.2013.07.005_bib0335","doi-asserted-by":"crossref","first-page":"22B","DOI":"10.1016\/j.amjcard.2013.01.058","article-title":"A novel polymer-free sirolimus-eluting stent coated with anti-CD34 Antibody shows less neointima formation and early recovery of endothelial function","volume":"111","author":"Zhang","year":"2013","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517313006091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517313006091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T23:31:28Z","timestamp":1563406288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517313006091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0378517313006091"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2013.07.005","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eluting combination drugs from stents","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2013.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}